CHILDREN'S ZYRTEC HIVES
Clinical safety rating: caution
Comprehensive clinical and safety monograph for CHILDREN'S ZYRTEC HIVES (CHILDREN'S ZYRTEC HIVES).
Cetirizine is a selective antagonist of peripheral histamine H1 receptors, inhibiting histamine-mediated allergic reactions.
| Metabolism | Cetirizine is minimally metabolized in the liver (<30%) via oxidative pathways; primarily excreted unchanged in urine. |
| Excretion | Cetirizine is primarily excreted renally (~60% unchanged), with ~10% fecal excretion. |
| Half-life | Terminal elimination half-life is approximately 8-11 hours in healthy adults, allowing twice-daily dosing. |
| Protein binding | Cetirizine is ~93% bound to plasma proteins (primarily albumin). |
| Volume of Distribution | Vd is approximately 0.3-0.5 L/kg, indicating distribution into total body water. |
| Bioavailability | Oral bioavailability is ~100% for cetirizine (minimal first-pass metabolism). |
| Onset of Action | Oral: onset in 1 hour; peak effect at 4-8 hours. |
| Duration of Action | Duration is approximately 24 hours, supporting once-daily dosing for symptom relief. |
| Molecular Weight | 388.89 |
5 mg or 10 mg orally once daily; maximum 10 mg/day.
| Dosage form | SOLUTION |
| Renal impairment | GFR 11-31 mL/min: 5 mg once daily. GFR <11 mL/min or dialysis: 5 mg every 2-3 days. Not recommended in ESRD. |
| Liver impairment | Mild hepatic impairment (Child-Pugh A): no adjustment. Moderate (Child-Pugh B): 5 mg once daily. Severe (Child-Pugh C): not recommended. |
| Pediatric use | Children 6 months to <2 years: 2.5 mg (2.5 mL) once daily; maximum 2.5 mg/day. Children 2-5 years: 2.5 mg (2.5 mL) once daily; maximum 5 mg/day. Children 6-11 years: 5 mg (5 mL) once daily; maximum 10 mg/day. |
| Geriatric use | Elderly patients: start at 5 mg once daily due to decreased renal function; increase cautiously. |
| 1st trimester | Use only if clearly needed; no adequate well-controlled studies in pregnant women. Animal studies have shown no evidence of harm at doses up to 20 times the human dose, but risk cannot be ruled out. |
| 2nd trimester | Generally considered safe; no known teratogenic effects. Use only if potential benefit justifies risk to fetus. |
| 3rd trimester | Avoid use near term due to potential histamine-related effects on uterine contractions, although cetirizine has not been associated with significant adverse effects. Use with caution. |
Clinical note
Comprehensive clinical and safety monograph for CHILDREN'S ZYRTEC HIVES (CHILDREN'S ZYRTEC HIVES).
| Placental transfer | Cetirizine crosses the placenta; levels in fetal cord blood are approximately 25-50% of maternal serum concentrations. |
| Breastfeeding | Cetirizine is excreted into breast milk in small amounts (approximately 3-6% of maternal weight-adjusted dose). The American Academy of Pediatrics considers it compatible with breastfeeding. Monitor infant for drowsiness, irritability, or other anticholinergic effects. |
■ FDA Black Box Warning
None
| Serious Effects |
Hypersensitivity to cetirizine or any formulation componentsSevere renal impairment (CrCl < 10 mL/min)
| Precautions | Avoid use in patients with severe renal impairment (CrCl <10 mL/min), Use with caution in patients with hepatic impairment, May cause drowsiness; caution with driving or operating machinery, Avoid concomitant use with CNS depressants |
| Food/Dietary | No significant food interactions. Grapefruit juice does not affect cetirizine. Food may slightly delay absorption but not reduce efficacy. Avoid alcohol and CNS depressants due to additive sedation. |
| Clinical Pearls |
Loading safety data…
| Lactation Rating | L2 (Safer) |
| Teratogenic Risk | Cetirizine is FDA Pregnancy Category B. Animal studies have not shown teratogenic effects. There are no adequate and well-controlled studies in pregnant women. First trimester data from the Swedish Medical Birth Registry (1995-2001) with 917 exposures showed no increased risk of major malformations. Second and third trimester use is not associated with fetal harm. However, due to the anticholinergic effects, use near term may cause neonatal effects such as irritability, tremors, and urinary retention. |
| Fetal Monitoring | No specific monitoring required beyond standard prenatal care. Monitor for maternal sedation, especially if other CNS depressants are used. In neonates exposed near term, observe for transient symptoms such as irritability or tremors. |
| Fertility Effects | Cetirizine has no known significant effects on human fertility. Animal studies at high doses showed no impairment of fertility. No clinical data suggest adverse effects on spermatogenesis or ovulatory function. |
| Children's Zyrtec Hives contains cetirizine, a second-generation antihistamine. Onset of action is within 1 hour; duration is 24 hours. For hives, consider dosing based on weight: 2.5 mg (1/2 tsp) for ages 2-5, 5 mg (1 tsp) for ages 6-11. May cause drowsiness; avoid concurrent CNS depressants. Can be used with food to reduce GI upset. |
| Patient Advice | Measure dose with provided dropper or syringe for accuracy. · Give once daily; do not exceed recommended dose. · May cause drowsiness; avoid driving or operating machinery if affected. · Do not use with any other antihistamine-containing products. · Stop use and consult doctor if hives worsen or symptoms persist >3 days. · For children under 2 years, use only under healthcare provider guidance. |